IGO Q3 2026 slides show strong cash flow despite operational hurdles

The market is treating this as a simple “good nickel, bad lithium” quarter, but the deeper read is that IGO is moving from a growth-and-ramp story into a quality-of-operations story. Nova is now behaving like a late-life cash machine: rising output, falling unit costs, and strong free cash flow even as it nears depletion. That matters because every dollar of Nova cash now has higher strategic value — it can either fund remediation at Greenbushes/Kwinana or be returned to holders, making capital allocation the next incremental driver of equity returns.

Greenbushes is the real swing factor, and the risk is not just lower volume; it is a credibility discount that can persist well beyond one quarter. Safety resets plus recovery underperformance create a second-order effect: even if spodumene prices stay firm, the market will haircut the sustainability of EBITDA margins until there is evidence the plant is structurally stabilized. The visible capex reduction is not automatically positive — in a high-incident operating environment, lower spend can read as deferral rather than efficiency, which is a classic setup for another reset later in the year.

The contrarian angle is that consensus may be over-penalizing the stock for near-term lithium operational noise while underestimating the earnings bridge from price recovery. If lithium prices hold anywhere near current levels, Greenbushes can still be a strong cash generator even at lower volumes, so the equity may already be discounting a much worse medium-term outcome than is likely. The cleaner trade, however, is not to chase outright long exposure; it is to separate the cash engine from the execution risk, because Kwinana remains the weakest link and can absorb improved upstream economics through downstream losses.